The Effects of Albuterol and Ipratropium Bromide on COPD Patients Bronchodilation Test

张荣葆,何权瀛,陈青,王慧玲,李雪亮,黄学萍,魏敬安

DOI: https://doi.org/10.3969/j.issn.1001-0025.2004.03.006

2004-01-01

Abstract:To compare consistency of 200 μg albuterol and 80 μg Ipratropium Bromide as bronchodilator in pulmonary function test in COPD patients. Methods:40 COPD patients were included in this study. Each patient in-spired 200 μg albuterol or 80 μg Ipratropium Bromide in random order. The pulmonary functions were evaluated in the changing amount of FEV1, improving rates of FEV1,PEF, Raw, DLCO and test positive rate. Results:The changing a-mount of FEV1, improving rates of FEV1,PEF, Raw, DLCO and test positive rate were not significantly different be-tween COPD patients inspiring 200 μg albuterol and 80 μg Ipratropium Bromide . The changing ammount of FEV1, im-proving rates of FEV1, and test positive rate were higher in exacerbation of COPD patients than in stable ones (P0. 01). Conclusion:The bronchodilative efficiency is the same in inspiring 200 μg albuterol or 80 μg Ipratropium Bro-mide . 80μg Ipratropium Bromide is an ideal choice for patients with prohibition to β2 receptor agonist in bronchodila-tion test.